Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
about
Glucose-regulated protein 78 demonstrates antiviral effects but is more suitable for hepatocellular carcinoma prevention in hepatitis B.Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion.Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling.Proteasomes regulate hepatitis B virus replication by degradation of viral core-related proteins in a two-step manner.Furin inhibitor D6R suppresses epithelial-mesenchymal transition in SW1990 and PaTu8988 cells via the Hippo-YAP signaling pathway.
P2860
Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
@en
Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
@nl
type
label
Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
@en
Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
@nl
prefLabel
Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
@en
Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
@nl
P2093
P2860
P356
P1433
P1476
Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
@en
P2093
Xiao J Tan
Xiao M Peng
Yan J Pang
Zi H Zheng
P2860
P304
P356
10.1111/LIV.12185
P577
2013-04-25T00:00:00Z